Marathon Capital Management Ani Pharmaceuticals Inc Transaction History

Marathon Capital Management

$387 Million
Q4 2024

A detailed history of Marathon Capital Management transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Marathon Capital Management holds 69,895 shares of ANIP stock, worth $4.49 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares

69,895

Previous 70,045 0.21%

Holding current value

$4.49 Million

Previous $4.18 Million 7.54%

% of portfolio

1.0%

Previous 1.05%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$53.35 - $61.74 $8,002 - $9,261	-150 Reduced 0.21%	69,895 $3.86 Million
Q3 2024 Nov 14, 2024	SELL	$54.33 - $65.72 $13,582 - $16,430	-250 Reduced 0.36%	70,045 $4.18 Million
Q2 2024 Aug 14, 2024	SELL	$58.53 - $68.82 $51,213 - $60,217	-875 Reduced 1.23%	70,295 $4.48 Million
Q1 2024 May 15, 2024	BUY	$54.2 - $69.69 $73,170 - $94,081	1,350 Added 1.93%	71,170 $4.92 Million
Q4 2023 Feb 08, 2024	SELL	$48.72 - $65.43 $90,132 - $121,045	-1,850 Reduced 2.58%	69,820 $3.85 Million
Q3 2023 Nov 14, 2023	BUY	$50.28 - $64.61 $152,097 - $195,445	3,025 Added 4.41%	71,670 $4.16 Million
Q2 2023 Aug 14, 2023	SELL	$37.29 - $53.83 $605,776 - $874,468	-16,245 Reduced 19.14%	68,645 $3.7 Million
Q1 2023 May 12, 2023	BUY	$37.61 - $45.72 $451,320 - $548,640	12,000 Added 16.46%	84,890 $3.37 Million
Q3 2022 Nov 14, 2022	SELL	$29.83 - $38.01 $46,833 - $59,675	-1,570 Reduced 2.11%	72,890 $2.34 Million
Q2 2022 Aug 12, 2022	SELL	$23.09 - $33.46 $12,699 - $18,403	-550 Reduced 0.73%	74,460 $2.21 Million
Q1 2022 May 13, 2022	BUY	$26.91 - $47.15 $6,458 - $11,316	240 Added 0.32%	75,010 $2.11 Million
Q4 2021 Feb 09, 2022	BUY	$32.97 - $56.85 $18,957 - $32,688	575 Added 0.77%	74,770 $3.45 Million
Q3 2021 Nov 15, 2021	BUY	$26.48 - $35.99 $1.96 Million - $2.67 Million	74,195 New	74,195 $2.44 Million

Others Institutions Holding ANIP

# of Institutions

211

Shares Held

19.2M

Call Options Held

3.4K

Put Options Held

10.8K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.12B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Capital Management with notifications on news.

Account

Marathon Capital Management Ani Pharmaceuticals Inc Transaction History